Bang YJ - Search Results

1

Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.

Park S, Ock CY, Kim H, Pereira S, Park S, Ma M, Choi S, Kim S, Shin S, Aum BJ, Paeng K, Yoo D, Cha H, Park S, Suh KJ, Jung HA, Kim SH, Kim YJ, Sun JM, Chung JH, Ahn JS, Ahn MJ, Lee JS, Park K, Song SY, Bang YJ, Choi YL, Mok TS, Lee SH. Park S, et al. Among authors: bang yj. J Clin Oncol. 2022 Jun 10;40(17):1916-1928. doi: 10.1200/JCO.21.02010. Epub 2022 Mar 10. J Clin Oncol. 2022. PMID: 35271299 Free PMC article.

2

In vitro generation of immune effector cells from tumor-associated lymphocytes of human gastric cancer.

Kim HJ, Heo DS, Suh CI, Kim HT, Bang YJ, Kim NK. Kim HJ, et al. Among authors: bang yj. Anticancer Res. 1995 Jul-Aug;15(4):1247-55. Anticancer Res. 1995. PMID: 7654004

3

Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells.

Kang SH, Bang YJ, Jong HS, Seo JY, Kim NK, Kim SJ. Kang SH, et al. Among authors: bang yj. Br J Cancer. 1999 Jun;80(8):1144-9. doi: 10.1038/sj.bjc.6690478. Br J Cancer. 1999. PMID: 10376964 Free PMC article.

4

Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients.

Kim CW, Choi SH, Chung EJ, Lee MJ, Byun EK, Ryu MH, Bang YJ. Kim CW, et al. Among authors: bang yj. Pathobiology. 1999 May-Jun;67(3):123-8. doi: 10.1159/000028061. Pathobiology. 1999. PMID: 10394132

5

Polyomavirus interstitial nephritis in a patient with EBV-negative B-cell posttransplantation lymphoproliferative disorder.

Oh JE, Bang YJ, Ahn C, Oh MD, Whang DY, Kim KW, Han JS, Kim S, Lee JS, Kim SJ, Kim SH, Lee HS. Oh JE, et al. Among authors: bang yj. Transplant Proc. 2001 Jun;33(4):2583-7. doi: 10.1016/s0041-1345(01)02104-2. Transplant Proc. 2001. PMID: 11406254 No abstract available.

6

Prognostic factors of Krukenberg's tumor.

Kim HK, Heo DS, Bang YJ, Kim NK. Kim HK, et al. Among authors: bang yj. Gynecol Oncol. 2001 Jul;82(1):105-9. doi: 10.1006/gyno.2001.6210. Gynecol Oncol. 2001. PMID: 11426970

7

Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.

Kim HK, Park IA, Heo DS, Noh DY, Choe KJ, Bang YJ, Kim NK. Kim HK, et al. Among authors: bang yj. Eur J Surg Oncol. 2001 Aug;27(5):464-71. doi: 10.1053/ejso.2001.1137. Eur J Surg Oncol. 2001. PMID: 11504517

8

Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer.

Wu HG, Bang YJ, Choi EK, Ahn YC, Kim YW, Lim TH, Suh C, Park K, Park CI. Wu HG, et al. Among authors: bang yj. Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):75-80. doi: 10.1016/s0360-3016(01)01739-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 11777624 Clinical Trial.

9

A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.

Kim TY, Yang SH, Lee SH, Park YS, Im YH, Kang WK, Ha SH, Park CI, Heo DS, Bang YJ, Kim NK. Kim TY, et al. Among authors: bang yj. Am J Clin Oncol. 2002 Jun;25(3):238-43. doi: 10.1097/00000421-200206000-00007. Am J Clin Oncol. 2002. PMID: 12040280 Clinical Trial.

10

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer.

Han SW, Hwang PG, Chung DH, Kim DW, Im SA, Kim YT, Kim TY, Heo DS, Bang YJ, Kim NK. Han SW, et al. Among authors: bang yj. Int J Cancer. 2005 Jan 1;113(1):109-15. doi: 10.1002/ijc.20550. Int J Cancer. 2005. PMID: 15386420 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

645 results

Search Page